<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR522.html">Part 522
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 522.1410  Methylprednisolone.
                            </h3>
                            <p class="depth1"><em>(a)</em> Specifications. Each milliliter of suspension contains 20 or 40  milligrams (mg) of methylprednisolone acetate.</p><p class="depth1"><em>(b)</em> Sponsors. See Nos. 054628 and 054771 in Sec. 510.600(c) of this  chapter.</p><p class="depth1"><em>(c)</em> [Reserved]</p><p class="depth1"><em>(d)</em> Conditions of use--</p><p class="depth2"><em>(1)</em> Dogs--</p><p class="depth3"><em>(i)</em> Amount. Administer 2 to 40 mg  (up to 120 mg in extremely large breeds or dogs with severe involvement)  by intramuscular injection or up to 20 mg by intrasynovial injection.</p><p class="depth3"><em>(ii)</em> Indications for use. For treatment of inflammation and related  disorders; treatment of allergic and dermatologic disorders; and as  supportive therapy to antibacterial treatment of severe infections.</p><p class="depth3"><em>(iii)</em> Limitations. Federal law restricts this drug to use by or on  the order of a licensed veterinarian.</p><p class="depth2"><em>(2)</em> Cats--</p><p class="depth3"><em>(i)</em> Amount. Administer 10 to 20 mg by intramuscular  injection.</p><p class="depth3"><em>(ii)</em> Indications for use. For treatment of inflammation and related  disorders; treatment of allergic and dermatologic disorders; and as  supportive therapy to antibacterial treatment of severe infections.</p><p class="depth3"><em>(iii)</em> Limitations. Federal law restricts this drug to use by or on  the order of a licensed veterinarian.</p><p class="depth2"><em>(3)</em> Horses--</p><p class="depth3"><em>(i)</em> Amount. Administer 200 mg by intramuscular injection  or 40 to 240 mg by intrasynovial injection.</p><p class="depth3"><em>(ii)</em> Indications for use. For treatment of inflammation and related  disorders.</p><p class="depth3"><em>(iii)</em> Limitations. Do not use in horses intended for human  consumption. Federal law restricts this drug to use by or on the order  of a licensed veterinarian.  [43 FR 59058, Dec. 19, 1978, as amended at 51 FR 741, Jan. 8, 1986; 53  FR 40728, Oct. 18, 1988; 62 FR 35076, June 30, 1997; 76 FR 53051, Aug.  25, 2011; 78 FR 21060, Apr. 9, 2013; 79 FR 16191, Mar. 25, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
